These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension. Barau C, Frangie C, Goujard C, Tribut O, Parant F, Taburet AM, Durrbach A, Furlan V. Ther Drug Monit; 2009 Apr; 31(2):267-8. PubMed ID: 19214146 [Abstract] [Full Text] [Related]
25. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Wallemacq P, Goffinet JS, O'Morchoe S, Rosiere T, Maine GT, Labalette M, Aimo G, Dickson D, Schmidt E, Schwinzer R, Schmid RW. Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928 [Abstract] [Full Text] [Related]
26. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer. Griffey MA, Hock KG, Kilgore DC, Wei TQ, Duh SH, Christenson R, Scott MG. Clin Chim Acta; 2007 Sep; 384(1-2):48-51. PubMed ID: 17588555 [Abstract] [Full Text] [Related]
27. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry. Brown NW, Gonde CE, Adams JE, Tredger JM. Clin Chem; 2005 Mar; 51(3):586-92. PubMed ID: 15650031 [Abstract] [Full Text] [Related]
28. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer]. Yargui L, Berhoune A. Ann Biol Clin (Paris); 2008 Mar; 66(6):657-64. PubMed ID: 19091665 [Abstract] [Full Text] [Related]
29. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients. Morris RG, Salm P, Taylor PJ, Wicks FA, Theodossi A. Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125 [Abstract] [Full Text] [Related]
30. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. Braun F, Lorf T, Schütz E, Christians U, Grupp C, Sattler B, Canelo R, Sewing KF, Armstrong VW, Oellerich M, Ringe B. Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231 [No Abstract] [Full Text] [Related]
32. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients. Huet E, Morand K, Blanchet B, Astier A, Hulin A. Transplant Proc; 2004 Jun; 36(5):1317-20. PubMed ID: 15251322 [Abstract] [Full Text] [Related]
37. Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay. Tomita T, Homma M, Hasegawa Y, Kojima H, Ohkohchi N, Hori T, Kaneko M, Nakano Y, Tobe T, Kohda Y. Biol Pharm Bull; 2008 Jun; 31(6):1250-3. PubMed ID: 18520063 [Abstract] [Full Text] [Related]
38. Comparison of cyclosporine concentrations in renal transplant recipients using ACMIA and mFPIA methods. Kagawa Y, Yanagawa M, Muraki Y, Iwamoto T, Mizutani H, Sugimura Y, Kojima M. Clin Biochem; 2004 Nov; 37(11):1016-21. PubMed ID: 15498531 [Abstract] [Full Text] [Related]